AlphaLife Sciences

China-based clinical research SaaS service provider AlphaLife Sciences has reportedly raised “tens of millions” of US dollars in a Series A+ financing round. The round was led by Hankang Capital, with participation from B Capital. The proceeds will be used to further develop and expand the company’s next-generation clinical study…